Bausch & Lomb, Incorporated
Rochester, New York, 14609, United States
NCT Number: NCT06098937
Approximately thirty contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion study.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Rochester, New York, 14609, United States
Approximately 30 soft toric contact lens adapted subjects will be enrolled in this feasibility, bilateral, randomized, double masked (subject and investigator masked), repeated measures insertion study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If study eligibility is met, subjects will have lenses inserted in random, successive order. Subjects will be receiving each of the study lens types once, in a randomized order. The subject will wear each of the study contact lenses for approximately 10 minutes.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Kalifilcon A Daily Disposable Toric for Ametropia
Total1 for Astigmatism
Precision1 for Astigmatism
MyDay Toric
Time frame: 5 minutes after lens insertion
Primary gaze orientation is measured in degrees using a slit lamp and reticule.
Bausch & Lomb Incorporated
Industry
Orientation Characteristics of Kalifilcon A Daily Disposable Toric Contact Lenses Compared to Commercially Available Daily Disposable Toric Contact Lenses
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06775509
Astigmatism, Eye Diseases
Tarragona, Spain
View Trial DetailsNCT06784063
Astigmatism, Cataract
Bloomfield Hills, Michigan, United States
View Trial DetailsNCT06749496
Astigmatism, Eye Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT06967129
Astigmatism, Eye Diseases
Mission Viejo, California, United States
View Trial Details